PharmaCyte Biotech, Inc. — Director's Dealing 2023

Nov 22, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PharmaCyte Biotech, Inc. (PMCB)
CIK: 0001157075
Period of Report: 2023-11-20

Reporting Person: WALKER WAYNE REMELL (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-20	Stock Option (Right to Buy)	$2.18	A	61248	Acquired	2033-11-20	Common Stock (61248)	Direct